RxDoctor Payments Data

Jennifer Marnik Scalici, DO

Obstetrics · Centralia, WANPI 1760521579

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Biogen accounts for 90.9% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $12,131, more than ten times the $42 reported in 2020. Among obstetrics clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,188in general payments, 2019–2025

Across 63 payments — averaging $209.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$12K
  • Exeltis, USA Inc.$327
  • Minerva Surgical, Inc$264
  • Sage Therapeutics, LLC$203
  • Hologic Sales And Service, LLC$96
  • Myovant Sciences Inc.$76
  • plus $236 from 10 others

What the payments were for

  • Consulting fees$4,73636%
  • Speaking & faculty fees$6,76551%
  • Travel & lodging$2642%
  • Food & beverage$1,42311%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,188 in reported general payments places this provider in the 95th percentile of 20 obstetrics providers in Washington.

See all obstetrics providers in Washington

Medicare billing

Part B allowed, 2024
$9,274
Medicare patients
62
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DottiEstradiol14$953
ValacyclovirValacyclovir Hcl17$728
ProgesteroneProgesterone, Micronized14$440
Medroxyprogesterone Acetate11$425
Buspirone Hcl13$147
Ibuprofen22$128

Paid to pharmacies, not to this prescriber.

Other obstetrics in Centralia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →